tiprankstipranks
Trending News
More News >
TME Pharma N.V. (FR:ALTME)
:ALTME
France Market
Advertisement

TME Pharma N.V. (ALTME) Stock Forecast & Price Target

Compare
3 Followers
See the Price Targets and Ratings of:

ALTME Financial Forecast

ALTME Earnings Forecast

The previous quarter’s earnings for ALTME were -€0.03.
The previous quarter’s earnings for ALTME were -€0.03.
No data currently available

ALTME Sales Forecast

The previous quarter’s earnings for ALTME were €0.00.
The previous quarter’s earnings for ALTME were €0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Invest Securities Analyst forecast on FR:ALTME
Unknown Analyst
Invest Securities
Not Ranked
Invest Securities
Buy
Upgraded
05/27/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Invest Securities Analyst forecast on FR:ALTME
Unknown Analyst
Invest Securities
Not Ranked
Invest Securities
Buy
Upgraded
05/27/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering TME Pharma N.V.

1 Month
No data currently available
3 Months
No data currently available
1 Year
Unknown AnalystInvest Securities
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
upgraded a buy rating 4 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
No data currently available
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALTME Analyst Recommendation Trends

Rating
May 25
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, ALTME has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ALTME average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ALTME Stock Forecast FAQ

What is FR:ALTME’s average 12-month price target, according to analysts?
Currently, no data Available
What is FR:ALTME’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for FR:ALTME, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TME Pharma N.V. a Buy, Sell or Hold?
      TME Pharma N.V. has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is TME Pharma N.V.’s share price target?
        Currently, no data Available
        What do analysts say about TME Pharma N.V.?
        TME Pharma N.V.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of TME Pharma N.V.?
          To buy shares of FR:ALTME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis